Drugs Made In America Acquisition II Corp. (DMIIU) Treasury Shares (2024 - 2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Treasury Shares of $50.0 million for Q4 2025, little changed year-over-year from $50.0 million in Q4 2024, and little changed quarter-over-quarter from $50.0 million in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Treasury Shares (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Treasury Shares for 2 consecutive years, with $50.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares changed 0.0% year-over-year to $50.0 million; the TTM figure through Dec 2025 stood at $50.0 million (changed 0.0% YoY), while the FY2025 annual figure was $50.0 million, changed 0.0% from the prior year.
- Treasury Shares held at $50.0 million in Q4 2025 per DMIIU's latest filing, from $50.0 million in the prior quarter.
- Across five years, Treasury Shares topped out at $50.0 million in Q4 2024 and bottomed at $50.0 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.00 Mn |
| Dec 31, 2025 | 50.00 Mn |
| Sep 30, 2025 | 50.00 Mn |
| Sep 30, 2025 | 50.00 Mn |
| Dec 31, 2024 | 50.00 Mn |
| Dec 31, 2024 | 50.00 Mn |